Anatoly Broyde

Statistics

Publications

Citations

189

H-Index

Active since

2010

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Anatoly Broyde is an author at Amplyx Pharmaceuticals (United States) specializing in medicine, glucagon-like peptide-1 receptor agonists, and pharmacology.

Publications per year

2010–2010

Publications

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

Que Liu, Christen M. Anderson, Anatoly Broyde et al. · Cardiovascular Diabetology · 2010 · 124 citations · Full text

Medicine, Cardiology, Pharmacology +17

The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats

Que Liu, Lisa A. Adams, Anatoly Broyde et al. · Cardiovascular Diabetology · 2010 · 65 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–2 of 2